← Back to Search

Not Applicable

Acupuncture for Cancer-Related Cognitive Impairment

Phase 2
Waitlist Available
Led By Jun Mao, MD, MSCE
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Completed initial cancer treatment (surgery, chemotherapy, and/or radiation therapy) at least one month prior to study enrollment (patients receiving maintenance cancer treatment with hormonal or targeted therapies are permitted)
Must be willing to adhere to all study-related procedures, including randomization to one of the 2 possible choices: acupuncture or sham acupuncture
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial is testing whether acupuncture can help with cognitive difficulties in cancer patients.

Who is the study for?
This trial is for English-speaking adults over 18 who've finished initial cancer treatment at least a month ago and feel their memory or concentration has worsened since their diagnosis. They must not have active disease, recent acupuncture for cognition, certain psychiatric disorders, dementia, Parkinson's, or recent medication changes.Check my eligibility
What is being tested?
The study tests if acupuncture can help with cognitive issues in cancer patients. Participants will be randomly assigned to receive either real acupuncture or sham (placebo) acupuncture. There's also an option of a waiting period followed by optional acupuncture.See study design
What are the potential side effects?
Acupuncture may cause minor side effects like soreness or bruising at needle sites, fatigue, headache, and feeling dizzy during the session. Sham acupuncture involves non-penetrating needles which should have minimal to no side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I finished my initial cancer treatment over a month ago but may be on maintenance therapy.
Select...
I am willing to follow the study's procedures and accept being randomly assigned to real or sham acupuncture.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with breast, colorectal, prostate, or gynecological cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive difficulties as measured by the Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog)

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Wait-List ControlExperimental Treatment1 Intervention
This arm is Closed to accrual.
Group II: AcupunctureExperimental Treatment1 Intervention
Group III: Sham Acupuncture (SA)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,927 Previous Clinical Trials
591,359 Total Patients Enrolled
132 Trials studying Prostate Cancer
65,904 Patients Enrolled for Prostate Cancer
Jun Mao, MD, MSCEPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
9 Previous Clinical Trials
1,936 Total Patients Enrolled

Media Library

Acupuncture (Not Applicable) Clinical Trial Eligibility Overview. Trial Name: NCT04007770 — Phase 2
Acupuncture (Not Applicable) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04007770 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographical scope of this trial?

"Currently, 6 clinical sites are recruiting for this study. The nearby locations of Uniondale, Middletown and Commack can help to reduce the travel burden for participants who wish to join in on the trial. There are also other centres available should these not be suitable."

Answered by AI

Has the FDA sanctioned Acupuncture as a valid medical therapy?

"The safety of Acupuncture is rated at 2 due to Phase 2 trial findings, which provide evidence for its protective qualities but not yet effectiveness."

Answered by AI

Is this research endeavor currently enrolling participants?

"Per clinicaltrials.gov, this medical trial has ceased recruiting participants since it was last amended on May 16th 2022. Notwithstanding, 4377 additional studies are actively enrolling patients at the moment."

Answered by AI
~2 spots leftby Jul 2024